These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12379149)

  • 1. Anion- and pH-dependent activation of the soluble form of dopamine beta-hydroxylase.
    Terland O; Flatmark T
    Biochem J; 2003 Feb; 369(Pt 3):675-9. PubMed ID: 12379149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
    Boyadzhyan AS; Karagezyan KG
    Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Hydroxyguanidines oxidation by a N3S copper-complex mimicking the reactivity of Dopamine beta-Hydroxylase.
    Slama P; Boucher JL; Réglier M
    J Inorg Biochem; 2009 Mar; 103(3):455-62. PubMed ID: 19178946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cytochrome cbo from the obligate methylotroph Methylobacillus flagellatus KT is a cytochrome-c oxidase].
    Strom EV; Dinarieva TIu; Hetrusov AI
    Mikrobiologiia; 2004; 73(2):157-62. PubMed ID: 15198024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N,N,N',N'-tetramethyl-1,4-phenylenediamine: a facile electron donor and chromophoric substrate for dopamine beta-monooxygenase.
    Wimalasena K; Wimalasena DS
    Biochem Biophys Res Commun; 1991 Mar; 175(3):920-7. PubMed ID: 2025264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase.
    Slama P; Boucher JL; Réglier M
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1081-7. PubMed ID: 15044095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
    Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
    FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of ascorbate oxidase: unexpected similarity to the reduction site of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1471-6. PubMed ID: 7945293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity.
    Maurus R; Begum A; Williams LK; Fredriksen JR; Zhang R; Withers SG; Brayer GD
    Biochemistry; 2008 Mar; 47(11):3332-44. PubMed ID: 18284212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of membrane-bound dopamine beta-hydroxylase from the cytoplasmic surface of the chromaffin-granule membrane.
    Grouselle M; Phillips JH
    Biochem J; 1982 Mar; 202(3):759-70. PubMed ID: 7092843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of tubulin by vanadate ion.
    Correia JJ; Lipscomb LD; Dabrowiak JC; Isern N; Zubieta J
    Arch Biochem Biophys; 1994 Feb; 309(1):94-104. PubMed ID: 8117118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration.
    Menniti FS; Knoth J; Diliberto EJ
    J Biol Chem; 1986 Dec; 261(36):16901-8. PubMed ID: 3097015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formation of non-soluble complexes between polyethyleneimine-anions and their potential use to isolate enzymes.
    Boeris V; Cassane C; Wagner J; Picó G
    Colloids Surf B Biointerfaces; 2011 Feb; 82(2):354-8. PubMed ID: 20932724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihalide and pseudohalide radical anions as oxidizing agents in nonaqueous solvents.
    Michalski R; Sikora A; Adamus J; Marcinek A
    J Phys Chem A; 2010 Jan; 114(2):861-6. PubMed ID: 19916511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
    Fitzpatrick PF; Harpel MR; Villafranca JJ
    Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.
    Wimalasena DS; Jayatillake SP; Haines DC; Wimalasena K
    Biochem J; 2002 Oct; 367(Pt 1):77-85. PubMed ID: 12038965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
    Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
    Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.